Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04087811 · ClinicalTrials.gov registry record
Postmarket Registry for Evaluation of the Superion® Spacer
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 1,674
- Enrollment target
NCT04087811: Completed study, sponsored by Boston Scientific Corporation.
NCT04087811 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 1,674 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04087811 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 1,674 participants
- Enrollment target
Study Summary
To gather evidence documenting the performance and clinical outcomes associated with treatment of moderate degenerative lumbar spinal stenosis using the Superion® Indirect Decompression System (IDS).
Primary Outcome
Percentage of patients reporting satisfied or somewhat satisfied with treatment during study follow up was calculated. Patients chose one of the following options to describe their overall satisfaction with their treatment (1) Satisfied (2) Somewhat Satisfied (3) Somewhat Dissatisfied (4) Dissatisfied. The percentage of patients who reported (1) Satisfied or (2) Somewhat satisfied were included and calculated in the analysis. Maximum is 100% of patients reported being satisfied and minimum is 0
Interventions
- DEVICE Superion® Indirect Decompression System (IDS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,674 participants |
| Start Date | 2016-11-28 |
| Est. Completion | 2021-03-01 |
What the finished NCT04087811 record still lists
NCT04087811 is an observational study that tracks outcomes without assigning an intervention. Its 1,674 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Superion® Indirect Decompression System (IDS) is the first listed.
NCT04087811 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04087811 about?
NCT04087811 is a clinical study titled "Postmarket Registry for Evaluation of the Superion® Spacer". To gather evidence documenting the performance and clinical outcomes associated with treatment of moderate degenerative lumbar spinal stenosis using the Superion® Indirect Decompression System (IDS).
What is the current status of trial NCT04087811?
This trial is currently completed. The enrollment target is 1,674 participants. The study started on 2016-11-28. Estimated completion is 2021-03-01.
What interventions are being tested in trial NCT04087811?
The interventions under investigation include: Superion® Indirect Decompression System (IDS) (DEVICE).
Who is sponsoring clinical trial NCT04087811?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04852887 · 1,670 participants · Phase 3
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- NCT06376565 · 1,680 participants · NA
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
- NCT06644625 · 1,665 participants
CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
- NCT06034405 · 1,663 participants
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI